Phillips-Medisize, in collaboration with its customer, Ascendis Pharma, was recently recognized with a third industry award for the Skytrofa Auto-Injector. The Red Dot Award recognizes the drug ...

TOKYO--(BUSINESS WIRE)--SHL, the world’s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices, announced today that SHL Marketing Director Steven Kaufman will ...

- Supply agreement supports Viridian’s development of potential first- and best-in-class subcutaneous therapies for treatment of thyroid eye disease (TED) - - Ypsomed brings strong track record of ...

Kaléo, a global leader in drug-delivery device combinations and auto-injector innovation and the makers of the only epinephrine auto-injector with voice guidance, AUVI-Q ® (epinephrine injection), ...

(RTTNews) - Ypsomed Holding AG (YPHDF) announced Monday that its digital connectivity add-on, SmartPilot, has received 510(k) clearance from the U.S. Food and Drug Administration or FDA. SmartPilot ...

Instron’s CT6 can be configured as an automated solution for the required testing of auto-injection devices – providing the benefits of automation without the additional complexity of a fully ...

The cost of epinephrine auto-injector devices, commonly known as "EpiPen" devices, is slated to become a little more affordable for families due to legislation recently signed into law in New York.

Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global leader in diabetes care technology, today announced that it has completed its previously announced transaction to acquire Owen Mumford Holdings ...

The growth hormone therapy market had become crowded and static. With little variety in the efficacy of drugs or treatments on offer, Merck Serono wanted to develop a device that would achieve ...

Anaphylaxis is a serious, potentially life-threatening allergic reaction that can affect several organ systems in the body and may threaten breathing and blood circulation. The most common causes of ...

WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare ...